| [1] |
Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.Nat Med,1997,3:730-737.
|
| [2] |
Reya T,Morrison SJ,Clarke MF,et al.Stem cells,cancer,and cancer stem cells.Nature,2001,414:105-111.
|
| [3] |
Esmailpour T,Huang TS.Advancement in mammary stem cell research.J Cancer,2008,4:131-138.
|
| [4] |
Al-Hajj M,Wicha MS,Benito-Hernandez A,et al.Prospective identification of tumorigenic breast cancer cells.Proc Natl Acad Sci USA,2003,100:3983-3988.
|
| [5] |
Huber KE,Carey LA,Wazer DE.Breast cancer molecular subtypes in patients with locally advanced disease:impact on prognosis,patterns of recurrence,and response to therapy.Semin Radiat Oncol,2009,19:204-210.
|
| [6] |
Sheridan C,Kishimoto H,Fuchs RK,et al.CD44+/CD24-breast cancer cells exhibit enhanced invasive properties:an early step necessary for metastasis.Breast Cancer Res,2006,8:R59.
|
| [7] |
Nalwoga H,Arnes JB,Wabinga H,et al.Expression of aldehyde dehydrogenase 1(ALDH1)is associated with basal-like markers and features of aggressive tumours in African breast cancer.Br J Cancer,2010,102:369-375.
|
| [8] |
Horwitz KB,Dye WW,Harrell JC,et al.Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts.Proc Natl Acad Sci USA,2008,105:5774-5779.
|
| [9] |
Li Y,Welm B,Podsypanina K,et al.Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.Proc Natl Acad Sci USA,2003,100:15853-15858.
|
| [10] |
Bouras T,Pal B,Vaillant F,et al.Notch signaling regulates mammary stem cell function and luminal cell-fate commitment.Cell Stem Cell,2008,3:429-441.
|
| [11] |
Liu S,Dontu G,Mantle ID,et al.Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.Cancer Res,2006,66:6063-6071.
|
| [12] |
Katayama R,Koike S,Sato S,et al.Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export.Cancer Sci,2009,100:2060-2068.
|
| [13] |
Fillmore CM,Kuperwasser C.Human breast cancer cell lines contain stem-like cells that self-renew,give rise to phenotypically diverse progeny and survive chemotherapy.Breast Cancer Res,2008,10:R25.
|
| [14] |
Shafee N,Smith CR,Wei S,et al.Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.Cancer Res,2008,68:3243-3250.
|
| [15] |
Steiniger SC,Coppinger JA,Kruger JA,et al.Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population.Stem Cells,2008,26:3037-3046.
|
| [16] |
Gupta PB,Onder TT,Jiang G,et al.Identification of selective inhibitors of cancer stem cells by high-throughput screening.Cell,2009,138:645-659.
|
| [17] |
Wright MH,Calcagno AM,Salcido CD,et al.Brca1 breast tumors contain distinct CD44+/CD24-and CD133+cells with cancer stem cell characteristics.Breast Cancer Res,2008,10:R10.
|
| [18] |
Tanei T,Morimoto K,Shimazu K,et al.Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.Clin Cancer Res,2009,15:4234-4241.
|
| [19] |
Li X,Lewis MT,Huang J,et al.Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.J Natl Cancer Inst,2008,100:672-679.
|
| [20] |
Chang JC,Li X,Wong H,et al.Therapeutic resistance and tumor-initiation:Molecular pathways involved in breast cancer stem cell self-renewal.http://meeting.ascopubs.org/cgi/content/abstract/25/18_supple/528.
|
| [21] |
Phillips TM,McBride WH,Pajonk F.The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.J Natl Cancer Inst,2006,98:1777-1785.
|
| [22] |
Al-Assar O,Muschel RJ,Mantoni TS,et al.Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers.Int J Radiat Oncol Biol Phys,2009,75:1216-1225.
|
| [23] |
Diehn M,Cho RW,Lobo NA,et al.Association of reactive oxygen species levels and radioresistance in cancer stem cells.Nature,2009,458:780-783.
|
| [24] |
Asselin-Labat ML,Shackleton M,Stingl J,et al.Steroid hormone receptor status of mouse mammary stem cells.J Natl Cancer Inst,2006,98:1011-1014.
|
| [25] |
Shipitsin M,Campbell LL,Argani P,et al.Molecular definition of breast tumor heterogeneity.Cancer Cell,2007,11:259-273.
|
| [26] |
Holland PA,Knox WF,Potten CS,et al.Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast.J Natl Cancer Inst,1997,89:1059-1065.
|
| [27] |
Farnie G,Clarke RB.Mammary stem cells and breast cancer:role of Notch signalling.Stem Cell Rev,2007,3:169-175.
|
| [28] |
Mani SA,Guo W,Liao MJ,et al.The epithelial-mesenchymal transition generates cells with properties of stem cells.Cell,2008,133:704-715.
|
| [29] |
Korkaya H,Paulson A,Iovino F,et al.HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.Oncogene,2008,27:6120-6130.
|
| [30] |
Rizzo P,Miao H,D'Souza G,et al.Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches.Cancer Res,2008,68:5226-5235.
|
| [31] |
Bedard PL,Cardoso F,Piccart-Gebhart MJ.Stemming resistance to HER-2 targeted therapy.J Mammary Gland Biol Neoplasia,2009,14:55-66.
|
| [32] |
Nahta R,Yu D,Hung MC,et al.Mechanisms of disease:understanding resistance to HER2-targeted therapy in human breast cancer.Nat Clin Pract Oncol,2006,3:269-280.
|
| [33] |
Roesler R,Cornelio DB,Abujamra AL,et al.HER2 as a cancer stem-cell target.Lancet Oncol,2010,11:225-226.
|
| [34] |
Hwang-Verslues WW,Kuo WH,Chang PH,et al.Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.PLoS One,2009,4:e8377.
|
| [35] |
Magnifico A,Albano L,Campaner S,et al.Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab.Clin Cancer Res,2009,15:2010-2021.
|
| [36] |
Jones KL,Buzdar AU.Evolving novel anti-HER2 strategies.Lancet Oncol,2009,10:1179-1187.
|
| [37] |
Palyi-Krekk Z,Barok M,Kovacs T,et al.EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding,internalization and motogenic effect of CD44.Cancer Lett,2008 18;263:231-242.
|
| [38] |
Ghatak S,Misra S,Toole BP.Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway.J Biol Chem,2002,277:38013-38020.
|
| [39] |
Tripathy D,Mukhopadhyay P,Verma U,et al.Targeting the chemokine receptor CXCR4 in trastuzumab resistance.Presented at the 30th Annual San Antonio Breast Cancer Symposium;December 13-16,2007;San Antonio,Texas.
|
| [40] |
Nagata Y,Lan KH,Zhou X,et al.PTEN activation contributes to tumor inhibition by trastuzumab,and loss of PTEN predicts trastuzumab resistance in patients.Cancer Cell,2004,6:117-127.
|